News
The Supreme Court on Friday rejected a challenge to the structure of a Department of Health and Human Services task force ...
The Supreme Court on Friday granted the HIV-prevention field a historic win — yet with a major caveat — as it upheld a ...
11hon MSN
The Supreme Court on Friday upheld the structure of a federal health task force that recommends preventive medical services ...
8d
KTVU FOX 2 on MSNNew HIV prevention drug introduced, but it comes at a high costAs with many chronic and often deadly diseases, an ounce of prevention can be worth a ton of cure. It's a breakthrough drug ...
The FDA approved Gilead's HIV prevention drug lenacapavir, a twice-a-year injectable medication that clinical trials show ...
A drug currently used to treat certain HIV infections has also, on Wednesday, received approval from the US Food and Drug ...
In a bold step toward global health justice, Ugandan biotech company DEI BioPharma has announced it will begin manufacturing ...
The twice-yearly injectable drug’s potential could be compromised by the Trump administration’s dramatic cuts to ...
The Food and Drug Administration approved the preventative use of lenacapavir, made by Gilead Sciences, on Wednesday. Experts ...
A newly approved HIV medication provides near-total protection against infection with just two injections a year. It's called Lenacapavir. But the high price of the drug could limit its reach.
Yeztugo, approved by the FDA, was highly effective in two randomized trials. It costs $28,218 per year, and people have to be HIV-negative to get it.
The drug is coming at a time when several studies aimed at finding an HIV cure or vaccine failed to yield expected results, even as the world races to end HIV/AIDs as a public health threat by 2030.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results